Cargando…

Real-World Use of Carvedilol in Children With Dilated Cardiomyopathy: Long-Term Effect on Survival and Ventricular Function

BACKGROUND: Carvedilol is recommended for chronic heart failure (HF) treatment in children. However, the ideal dosage and administration are not standardized, and data on its long-term effects are lacking. This study aimed to assess the effect of a high dosage regimen of carvedilol on cardiac outcom...

Descripción completa

Detalles Bibliográficos
Autores principales:	Adorisio, Rachele, Cantarutti, Nicoletta, Ciabattini, Marco, Amodeo, Antonio, Drago, Fabrizio
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2022
Materias:	Pediatrics
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9010785/ https://www.ncbi.nlm.nih.gov/pubmed/35433536 http://dx.doi.org/10.3389/fped.2022.845406

Ejemplares similares

Heart rate reduction as a marker to optimize carvedilol treatment and enhance myocardial recovery in pediatric dilated cardiomyopathy
por: Adorisio, Rachele, et al.
Publicado: (2022)

Duchenne Dilated Cardiomyopathy: Cardiac Management from Prevention to Advanced Cardiovascular Therapies
por: Adorisio, Rachele, et al.
Publicado: (2020)

Cardiovascular Involvement in Pediatric Laminopathies. Report of Six Patients and Literature Revision
por: Baban, Anwar, et al.
Publicado: (2020)

ICD Outcome in Pediatric Cardiomyopathies
por: Silvetti, Massimo Stefano, et al.
Publicado: (2022)

Comment on: ‘Implantation of a left ventricular assist device to provide long term support for end‐stage Duchenne muscular dystrophy‐associated cardiomyopathy’ by Stoller et al.
por: Adorisio, Rachele, et al.
Publicado: (2018)

The Role of Carvedilol in the Treatment of Dilated and Anthracyclines-Induced Cardiomyopathy
por: Watanabe, Kenichi, et al.
Publicado: (2011)

Effects of carvedilol therapy on cardiac autonomic control, QT dispersion, and ventricular arrhythmias in children with dilated cardiomyopathy
por: Oflaz, Mehmet Burhan, et al.
Publicado: (2013)

Higher Serum Lysophosphatidic Acids Predict Left Ventricular Reverse Remodeling in Pediatric Dilated Cardiomyopathy
por: Wen, Haichu, et al.
Publicado: (2021)

Long-Term Outcomes and Prognosticators of Pediatric Primary Dilated Cardiomyopathy in an Asian Cohort
por: Wang, Po-Yuan, et al.
Publicado: (2021)

Cardiac Manifestations in Children with SARS-COV-2 Infection: 1-Year Pediatric Multicenter Experience
por: Cantarutti, Nicoletta, et al.
Publicado: (2021)

Pulmonary Artery Banding for Ventricular Rehabilitation in Infants With Dilated Cardiomyopathy: Early Results in a Single-Center Experience
por: Di Candia, Angela, et al.
Publicado: (2020)

Evaluation of Drug-Related Receptors in Children With Dilated Cardiomyopathy
por: Guo, Qing, et al.
Publicado: (2019)

Predictive value of electrocardiographic markers in children with dilated cardiomyopathy
por: Wang, Miao, et al.
Publicado: (2022)

Feasibility of the Omaha system for the care of children with dilated cardiomyopathy
por: Zhang, Qin, et al.
Publicado: (2023)

Results of Late Gadolinium Enhancement in Children Affected by Dilated Cardiomyopathy
por: Muscogiuri, Giuseppe, et al.
Publicado: (2017)

Clinical efficacy of carvedilol treatment for dilated cardiomyopathy: A meta-analysis of randomized controlled trials
por: Li, Tao, et al.
Publicado: (2019)

Dilated Cardiomyopathy in Pediatric Crohn’s Patient: Is It a Manifestation or Consequence of Therapy?
por: Busaleh, Fadi, et al.
Publicado: (2021)

Development of Cardiac Events and Functional Recovery Prediction Models for Pediatric Dilated Cardiomyopathy
por: Kim, Dong-Hee, et al.
Publicado: (2021)

Long-term, real world experience of ventricular tachycardia and granulomatous cardiomyopathy
por: Bohora, Shomu, et al.
Publicado: (2022)

Wilms Tumor with dilated hypertensive cardiomyopathy, acute myocarditis, pulmonary edema, and heart failure
por: Chung, Jae Min, et al.
Publicado: (2020)

Differential Expression Profiles and Functional Analysis of Long Non-coding RNAs in Children With Dilated Cardiomyopathy
por: Cai, Dongxiao, et al.
Publicado: (2021)

Case Report: Dilated Cardiomyopathy in a Newborn, a Potential Association With SARS-COV-2
por: Azeka, Estela, et al.
Publicado: (2021)

The Changes of T-Wave Amplitude and QT Interval Between the Supine and Orthostatic Electrocardiogram in Children With Dilated Cardiomyopathy
por: Tan, Cheng, et al.
Publicado: (2021)

Treatment for Post-hemorrhagic Ventricular Dilatation: A Multiple-Treatment Meta-Analysis
por: Mahoney, Liam, et al.
Publicado: (2020)

Preventive role of carvedilol in adriamycin-induced cardiomyopathy
por: Jhorawat, Rajesh, et al.
Publicado: (2016)

Electrical Ventricular Remodeling in Dilated Cardiomyopathy
por: Mages, Christine, et al.
Publicado: (2021)

Efficacy of Carvedilol in Patients with Dilated Cardiomyopathy due to Beta-thalassemia major; a Double-blind Randomized Controlled Trial
por: Ajami, Gholam-Hossein, et al.
Publicado: (2010)

Review of Insulin Resistance in Dilated Cardiomyopathy and Implications for the Pediatric Patient Short Title: Insulin Resistance DCM and Pediatrics
por: Mak, Daniel, et al.
Publicado: (2021)

Hypertensive heart disease: Benefit of carvedilol in hemodynamic, left ventricular remodeling, and survival
por: Dominguez, Renata F, et al.
Publicado: (2019)

Prenatal case report of Barth syndrome caused by novel TAFAZZIN mutation: Clinical characteristics of fetal dilated cardiomyopathy with ascites
por: Zhao, Xuliang, et al.
Publicado: (2022)

Arrhythmogenic Right Ventricular Cardiomyopathy in Pediatric Patients: An Important but Underrecognized Clinical Entity
por: te Riele, Anneline S. J. M., et al.
Publicado: (2021)

Clinical Profile and Risk Factors for Cardiac Death in Pediatric Patients With Primary Dilated Cardiomyopathy at a Tertiary Medical Center in China
por: Wang, Yan, et al.
Publicado: (2022)

Carvedilol versus Metoprolol in Patients with Ventricular Tachyarrhythmias
por: Schupp, Tobias, et al.
Publicado: (2022)

A Rare Case of an Infant With 1p36 Deletion Syndrome Presenting With Systolic Heart Failure Secondary to Severe Dilated Cardiomyopathy
por: Ogbuji, Chukwunonye O, et al.
Publicado: (2023)

Arrhythmogenic Right Ventricular Cardiomyopathy: Characterization of Left Ventricular Phenotype and Differential Diagnosis With Dilated Cardiomyopathy
por: Cipriani, Alberto, et al.
Publicado: (2020)

Long-term nifekalant use in a patient with dilated cardiomyopathy and recurrent ventricular tachycardia
por: Xiao, Hongyan, et al.
Publicado: (2022)

Dynamic superior vena cava occlusion with an atrial implanted pediatric right ventricular assist device
por: Trezzi, Matteo, et al.
Publicado: (2021)

Reduced Systolic Function and Not Genetic Variants Determine Outcome in Pediatric and Adult Left Ventricular Noncompaction Cardiomyopathy
por: Schultze-Berndt, Alina, et al.
Publicado: (2021)

1p36 Deletion Syndrome and Left Ventricular Non-compaction Cardiomyopathy—Two Cases Report
por: Jang, Subin, et al.
Publicado: (2021)

Arrhythmogenic Right Ventricular Cardiomyopathy: Improvement of Diagnosis and Risk Stratification by Implementation of Echocardiographic Normative Values in Children
por: Kurath-Koller, Stefan, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_lvipe72j330gsu9ujgdpgephqm